ROYAL LONDON ASSET MANAGEMENT LTD
Position in HALO — Halozyme Therapeutics, Inc.
CIK 863748
UNITED KINGDOM, X0
Position in HALO
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$104,090,040
+$11,803,502 QoQ
Shares Held
1,610,553
+17.4% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 62.72094119224887.ToString("F0")%
Shared 0.ToString("F0")%
None 37.27905880775113.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $495,689,061 across 9 Biotechnology names. HALO ranks #3 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
3,808,353 | $182,686,693 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
252,192 | $112,613,815 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,610,553 | $104,090,040 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
215,075 | $71,161,865 | |
| 5 | INCY |
Incyte Corp
|
192,049 | $18,075,651 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,919 | $3,027,976 | |
| 7 | INSM |
INSMED Inc
|
14,498 | $2,370,712 | |
| 8 | LEGN |
Legend Biotech Corp
|
75,000 | $1,356,750 |
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $104,090,040 | 1,610,553 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $92,286,538 | 1,371,271 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $83,846,468 | 1,143,257 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $57,321,462 | 1,101,912 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,629,085 | 495,676 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||